Hong Kong and Shenzhen initiate cross-border clinical trials for oncology and ophthalmology treatments

Hong Kong and Shenzhen have formalized a collaboration to conduct large-scale clinical trials for two US-developed treatments targeting breast cancer and degenerative eye disease. The initiative leverages the Greater Bay Area International Clinical Trial Institute to integrate research infrastructure across the border, marking a significant step in regional medical integration.